These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 31517859

  • 1. Pediatric gastroenteropancreatic neuroendocrine tumor: A case report and review of the literature.
    Gaiani F, de'Angelis N, Minelli R, Kayali S, Carra MC, de'Angelis GL.
    Medicine (Baltimore); 2019 Sep; 98(37):e17154. PubMed ID: 31517859
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Molecular imaging with ⁶⁸Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours.
    Kaemmerer D, Peter L, Lupp A, Schulz S, Sänger J, Prasad V, Kulkarni H, Haugvik SP, Hommann M, Baum RP.
    Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1659-68. PubMed ID: 21626438
    [Abstract] [Full Text] [Related]

  • 5. HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic target.
    Gamboa AC, Ethun CG, Postlewait LM, Lopez-Aguiar AG, Zhelnin K, Krasinskas A, El-Rayes BF, Russell MC, Kooby DA, Staley CA, Cardona K, Maithel SK.
    Surg Oncol; 2020 Dec; 35():460-465. PubMed ID: 33080545
    [Abstract] [Full Text] [Related]

  • 6. [Pathological characteristics and survival analysis of 355 patients with gastroenteropancreatic neuroendocrine neoplasms].
    Li Y, Wang YF, Tan BB, Er LM, Zhao Q, Fan LQ, Zhang ZD, Liu Y.
    Zhonghua Zhong Liu Za Zhi; 2020 May 23; 42(5):426-431. PubMed ID: 32482035
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Gastroenteropancreatic neuroendocrine tumors : targeted diagnostics and therapy].
    Holzer K.
    Chirurg; 2014 Aug 23; 85(8):731-44. PubMed ID: 25103842
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. State of the Art in Endoscopic Therapy for the Management of Gastroenteropancreatic Neuroendocrine Tumors.
    Papaefthymiou A, Laskaratos FM, Koffas A, Manolakis A, Gkolfakis P, Coda S, Sodergren M, Suzuki N, Toumpanakis C.
    Curr Treat Options Oncol; 2022 Jul 23; 23(7):1014-1034. PubMed ID: 35511346
    [Abstract] [Full Text] [Related]

  • 11. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.
    Fang C, Wang W, Zhang Y, Feng X, Sun J, Zeng Y, Chen Y, Li Y, Chen M, Zhou Z, Chen J.
    Chin J Cancer; 2017 Jun 21; 36(1):51. PubMed ID: 28637502
    [Abstract] [Full Text] [Related]

  • 12. Gastroenteropancreatic-origin neuroendocrine carcinomas: Three case reports with favorable responses following localized radiotherapy and a review of literature.
    Won YG, Seo KJ, Hyeon J, Shin OR, Chang E, Sun S, Won HS, Ko YH, Na SJ, Lee SL, Ku YM, Lee DS.
    Medicine (Baltimore); 2017 Dec 21; 96(49):e9009. PubMed ID: 29245282
    [Abstract] [Full Text] [Related]

  • 13. Recent updates on grading and classification of neuroendocrine tumors.
    Kim JY, Hong SM, Ro JY.
    Ann Diagn Pathol; 2017 Aug 21; 29():11-16. PubMed ID: 28807335
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. APOBEC3B High Expression in Gastroenteropancreatic Neuroendocrine Neoplasms and Association With Lymph Metastasis.
    Feng C, Zheng Q, Yang Y, Xu M, Lian Y, Huang J, Jiang Y.
    Appl Immunohistochem Mol Morphol; 2019 Sep 21; 27(8):599-605. PubMed ID: 30095460
    [Abstract] [Full Text] [Related]

  • 16. [Gastroenteropancreatic neuroendocrine neoplasms-Surgery in a multimodal concept].
    Holzer K, Bartsch DK.
    Chirurgie (Heidelb); 2024 Sep 21; 95(9):773-782. PubMed ID: 38935138
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ki-67 Labeling Index Variability Between Surgically Resected Primary and Metastatic Hepatic Lesions of Gastroenteropancreatic Neuroendocrine Neoplasms.
    Furukawa T, Ozaka M, Takamatsu M, Takazawa Y, Inamura K, Inoue Y, Mie T, Takeda T, Kanata R, Kasuga A, Matsuyama M, Sasaki T, Takahashi Y, Sasahira N.
    Int J Surg Pathol; 2021 Aug 21; 29(5):475-481. PubMed ID: 33543658
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.